Abstract:Abstract Background Use of artificial intelligence, or machine learning, to assess dermoscopic images of skin lesions to detect melanoma has in several retrospective studies shown high levels of diagnostic accuracy on par with, or even outperforming, experienced dermatologists. However, the enthusiasm around these algorithms has not yet been matched by prospective clinical trials performed in authentic clinical settings. In several European countries, including Sweden, the initial clinical assessment of suspected skin cancer is principally conducted in the primary health care setting by primary care physicians; with or without access to teledermoscopic support from dermatology clinics. Objective To determine the diagnostic performance of an artificial intelligence-based clinical decision support tool for cutaneous melanoma detection, operated by a smartphone application (app), when used prospectively by primary care physicians to assess skin lesions of concern due to some degree of melanoma suspicion. Methods This prospective, multicentre, clinical trial was conducted at 36 primary care centres in Sweden. The physicians used the smartphone app on skin lesions of concern by photographing them dermoscopically, which resulted in a dichotomous decision support text regarding evidence for melanoma. Regardless of the app outcome, all lesions underwent standard diagnostic procedure, by surgical excision or referral to dermatologist. After completed investigation, lesion diagnoses were collected from the patients’ medical records and compared to app outcome and other lesion data. Results In total, 253 lesions of concern in 228 patients were included, of which 21 proved to be melanomas, with 11 thin invasive melanomas and 10 melanomas in situ. The app’s accuracy (95% confidence interval) in identifying melanomas was reflected in an area under the receiver operating characteristic (AUROC) curve of 0.960 (0.928-0.980), corresponding to a maximum sensitivity and specificity of 95.2% and 84.5%, respectively. For invasive melanomas alone, the AUROC was 0.988 (0.965–0.997), corresponding to a maximum sensitivity and specificity of 100% and 92.6%, respectively. Conclusions The clinical decision support tool evaluated in this investigation showed high diagnostic accuracy when used prospectively on primary care patients, which could add significant clinical value for primary care physicians in assessing skin lesions to detect melanoma. ClinicalTrials.gov Identifier: NCT05172232

Clinical performance of a novel hyperspectral imaging device for cutaneous melanoma and pigmented skin lesions in Caucasian skin

Non-Invasive Skin Cancer Diagnosis Using Hyperspectral Imaging for In-Situ Clinical Support

In Vivo Measurement and Modeling of Multispectral Reflectance Images for Melanoma Diagnosis

Near-infrared hyperspectral imaging and robust statistics for in vivo non-melanoma skin cancer and actinic keratosis characterisation

Distribution Quantification on Dermoscopy Images for Computer-Assisted Diagnosis of Cutaneous Melanomas

Classification of melanocytic lesions using direct illumination multispectral imaging

Pixel-level classification of pigmented skin cancer lesions using multispectral autofluorescence lifetime dermoscopy imaging

Identification of Skin Lesions by Snapshot Hyperspectral Imaging

Unsupervised sub-segmentation for pigmented skin lesions.

Prehistological evaluation of benign and malignant pigmented skin lesions with optical computed tomography

Evaluation of an artificial intelligence-based decision support for detection of cutaneous melanoma in primary care – a prospective, real-life, clinical trial

Using computational learning for non-melanoma skin cancer and actinic keratosis near-infrared hyperspectral signature classification

Unique spectral signature of human cutaneous squamous cell carcinoma by photoacoustic imaging

Exploring the feasibility of an artificial intelligence based clinical decision support system for cutaneous melanoma detection in primary care – a mixed method study

Elastic Scattering Spectroscopy on Patient-Selected Lesions Concerning for Skin Cancer

Single probe light reflectance spectroscopy and parameter spectrum feature extraction in experimental skin cancer detection and classification

500pd new diagnostic techniques in early diagnosis of melanoma in situ

Hyperspectral imaging for head and neck cancer detection: specular glare and variance of the tumor margin in surgical specimens

In Vivo Use of Hyperspectral Imaging to Develop A Noncontact Endoscopic Diagnosis Support System for Malignant Colorectal Tumors

Analytic validation of convolutional neural network-based classification of pigmented skin lesions (PSLs) using unseen PSL hyperspectral data for clinical applications

Combining hyperspectral imaging techniques with deep learning to aid in early pathological diagnosis of melanoma